Back to results
CompletedPhase 1

Study of Antibody Drug Conjugate in Patients With Advanced Breast Cancer Expressing HER2

NCT02952729

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Moffitt Cancer Center

Tampa, Florida, United States

+4 additional locations

View on ClinicalTrials.gov